Management of entecavir-resistant chronic hepatitis B with adefovir-based combination therapies

doi:10.3748/wjg.v21.i38.10874

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 38

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8057)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

439

WORD

302

HTML

3525

Figures (1-5)

242

Tables (1-4)

203

Sum=4711

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1237

Download

2109

Sum=3346

Oct 14, 2015 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Oct 14, 2015; 21(38): 10874-10882
Published online Oct 14, 2015. doi: 10.3748/wjg.v21.i38.10874

Full Size Figure Download Figure

Figure 1 Changes of hepatitis B virus DNA levels during 48 wk. A: The overall mean changes of hepatitis B virus (HBV) DNA levels from baseline; B: The mean reduction of serum HBV DNA levels in adefovir plus entecavir (ADV/ETV) combination group and in the adefovir plus lamivudine (ADV/LMV) combination group.

Citation: Kim HS, Yim HJ, Jang MK, Park JW, Suh SJ, Seo YS, Kim JH, Kim BH, Park SJ, Lee SH, Kim SG, Kim YS, Lee JI, Lee JW, Kim IH, Kim TY, Kim JW, Jeong SH, Jung YK, Park H, Group SGHOBOARS. Management of entecavir-resistant chronic hepatitis B with adefovir-based combination therapies. World J Gastroenterol 2015; 21(38): 10874-10882
URL: https://www.wjgnet.com/1007-9327/full/v21/i38/10874.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i38.10874